基于葡萄糖反应的纤维素凝的多模式核酸输送系统
Mangesh Morey1, Aitor Larrañaga1, Sunny Akogwu Abbah1
1CÚRAM, SFI Research Centre for Medical Devices, University of Galway, Galway, Ireland.
Advanced biology
|July 4, 2023
概括
这项研究提出了一种用于糖尿病伤口愈合的新型葡萄糖反应性水凝. 该系统有效地提供核酸,促进愈合和减少炎症,没有副作用.
科学领域:
- 生物材料科学 生物材料科学
- 基因治疗 基因治疗
- 伤口治愈研究研究 伤口治愈研究
背景情况:
- 核酸疗法提供了通过基因表达修饰的伤口愈合的潜力.
- 挑战包括核酸保护,生物响应传递和细胞转染.
- 一个对葡萄糖有反应的系统是糖尿病伤口治疗的理想选择,可调节分娩.
研究的目的:
- 为糖尿病伤口设计和评估一种对葡萄糖敏感的基因传递系统.
- 评估系统有效安全地加载和释放核酸的能力.
- 在糖尿病小鼠模型中研究该系统对伤口愈合的治疗效果.
主要方法:
- 使用层层的方法制造纤维素涂层聚合物微囊 (FCPMC).
- 在FCPMC系统中将核酸加载到多重组中.
- 在体外细胞毒性评估和体内研究糖尿病db/db小鼠的伤口.
主要成果:
- FCPMC系统有效地加载并持续释放核酸,没有观察到细胞毒性.
- 在糖尿病伤口的体内应用显示改善了再上皮化和血管生成.
- 该系统显著降低了炎症,并提高了关键的伤口愈合蛋白 (Actn2,MYBPC1,desmin).
结论:
- 开发的葡萄糖反应纤维素水凝 (GRFHG) 在糖尿病情况下有效促进伤口愈合.
- 该系统展示了多种治疗性核酸的联合交付潜力.
- 这种生物材料为治疗糖尿病伤口并发症提供了一个有希望的策略.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


